Dr. Kang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1300 N Vermont Ave
Los Angeles, CA 90027Phone+1 323-624-6297
Education & Training
- Loma Linda University Health Education ConsortiumResidency, Radiation Oncology, 2009 - 2013
- Olive View/UCLA Medical CenterInternship, Internal Medicine, 2008 - 2009
- Loma Linda University School of MedicinePh.D., Biochemistry, Thesis: Epigenetic implications of Inflammation mediated damage products of DNA and histone proteins; PI: Dr. Lawrence Sowers, Ph.D., 2002 - 2008
- Loma Linda University School of MedicineClass of 2008
Certifications & Licensure
- CA State Medical License 2010 - 2026
- AZ State Medical License 2017 - 2025
- OK State Medical License 2013 - 2014
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 13 citationsHypofractionated Proton Therapy in Early Prostate Cancer: Results of a Phase I/II Trial at Loma Linda University.Jason M. Slater, Jerry D. Slater, Joseph I. Kang, Ivan C. Namihas, B. Rodney Jabola
International Journal of Particle Therapy. 2019-08-06 - 6 citationsProton stereotactic body radiation therapy for liver metastases—results of 5-year experience for 81 hepatic lesionsAlex Coffman, Daniel C Sufficool, Joseph I. Kang, Chung-Tsen Hsueh, Sasha Swenson
Journal of Gastrointestinal Oncology. 2021-08-01 - 13 citationsA phase I trial of Proton stereotactic body radiation therapy for liver metastasesJoseph I. Kang, Daniel C. Sufficool, Chung-Tsen Hsueh, Andrew J. Wroe, Baldev Patyal
Journal of Gastrointestinal Oncology. 2018-09-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: